http://www.lineagecell.com
Lineage Cell Therapeutics, Inc. Company Intro
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Industry
Healthcare
Lineage Cell Therapeutics, Inc. Headquaters
2173 Salk Avenue
Carlsbad,92008
United States
Lineage Cell Therapeutics, Inc. Share price
17 May 2023 13:27 GMT
$1.3800
-0.01 (-0.72 %)
Lineage Cell Therapeutics, Inc. Market cap
$231.437 M
WMC RANKING
2023
Lineage Cell Therapeutics, Inc. # 232
BiotechnologyLatest Lineage Cell Therapeutics, Inc. News
05 Dec 2023
Global Autologous Cell Therapy Market Size, Exploring Digital ...
Pharmicell Co. Inc., Vericel Corporation, Castle Creek Biosciences Inc., Lineage Cell Therapeutics Inc., BrainStorm Cell Therapeutics, Regeneus Ltd., Takeda...
05 Dec 2023
Functional divergence of a bacterial enzyme promotes healthy ...
... lineage (Supplementary Fig. 7). Structures of HylA and HylB reveal high ... In an adoptive T cell transfer experiment, CD3+T cells from vaccinated mice...
05 Dec 2023
Zenas BioPharma Strengthens Executive Leadership with ...
... lineage cell activity. In several early-stage clinical studies, including in various autoimmune diseases, 198 subjects were treated with obexelimab. In...
WMC Market Score
WMC Market to Revenue Score
Lineage Cell Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Lineage Cell Therapeutics, Inc. | USD | $900 | $26,556 | $-13,666 | $2,314M | 232 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Lineage Cell Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Lineage Cell Therapeutics, Inc. Post vs Top 4 Industry Competitors
Lineage Cell Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Lineage Cell Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Lineage Cell Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Lineage Cell Therapeutics, Inc. | 0.01 | 1.46 | 0.08 | 0 | 0 | 0 | 0.66 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
